Yasmeen Rahimi

Yasmeen Rahimi

Analyst-Equity en Piper Sandler & Co. (Broker) .

Finance
Consumer Services
Health Technology

Perfil

Dr. Yasmeen Rahimi is a Senior Research Analyst at Piper Sandler & Co. She is also a director covering biotechnology.
Prior to joining Piper Sandler in July 2020, Dr. Rahimi was a senior research analyst and co-head of biotechnology equity research team at ROTH Capital Partners.
Before that, she worked as an equity research associate at H.C.
Wainwright & Co. and Guggenheim Securities.
Prior to making the transition to Wall Street, Rahimi was a research scientist at Shire Pharmaceuticals where she developed biomarker strategies for a number of rare disease programs; she has an extensive expertise in liver metabolism.
She received her Ph.D.
from Indiana University School of Medicine.
In addition, she has a M.S.
in Bioanalytical Chemistry from Purdue University and a joint B.A.
in German and Chemistry from Butler University.

Cargos activos de Yasmeen Rahimi

EmpresasCargoInicio
Analyst-Equity 01/07/2020
Todos los cargos activos de Yasmeen Rahimi

Antiguos cargos conocidos de Yasmeen Rahimi.

EmpresasCargoFin
Director de Investigación - Acciones 01/07/2020
Analyst-Equity 01/09/2017
Corporate Officer/Principal 01/06/2016
Corporate Officer/Principal 01/07/2015
Yale University Corporate Officer/Principal 01/11/2014
Ver el detalle de la experiencia de Yasmeen Rahimi.

Formación de Yasmeen Rahimi.

The Indiana University School of Medicine Doctorate Degree
Purdue University Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Yasmeen Rahimi.

Relaciones

100 +

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas5

Finance

Finance

Health Technology

Finance

Finance

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA